Look into the typical physician’s toolbox for preventing cardiovascular disease, and you’ll find two dominant tools: statin drugs and a blood test to determine if you need them. Twenty-eight years after pharmaceutical giant Merck rolled out the first cholesterol-lowering prescription drug, Lovastatin, (brand name Mevacor), statins have become the largest-selling class of drugs in the world, with one in four adults over age 40 taking them, and annu
All access premium subscription
This content requires a subscription to Nutrition Business Journal.
As an NBJ subscriber, you receive 10 issues a year and access to the exclusive “NBJ subscriber only” content on newhope.com (excludes three-month subscriptions), which includes PowerPoint presentations, select data charts and archived articles. Subscribers also receive a 10 percent discount on data charts, comprehensive market research reports and webinars.
Email [email protected] for more information about subscribing.